{"entity":{"type":"insider","cik":"0001562157","url":"/insider/0001562157","json_url":"/insider/0001562157.json","name":"Foresite Capital Fund I, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":4,"first":"2013-10-16","last":"2020-05-14","span_basis":"filed_date"},"name_variants":[{"name":"Foresite Capital Fund I, L.P.","source":"filing","n_filings":4,"first_seen":"2013-10-16","last_seen":"2020-05-14"}],"transactions":[{"id":2039810,"accession":"0000899243-20-013113","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-013113","line_url":"/filing/0000899243-20-013113","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management I, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Fund I, L.P.; Foresite Capital Management II, LLC","owner_display_name":"Tananbaum James B.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450000.0,"shares_display":"1,450,000","price_per_share":80.13,"price_display":"80.13","price_state":"stated","total_value":116188500.0,"total_display":"116,188,500.00","total_whole":"116,188,500","shares_owned_after":3500000.0,"shares_owned_after_display":"3,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-14","scope":"insider","n_lines":2},{"id":2244463,"accession":"0000899243-20-009021","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-009021","line_url":"/filing/0000899243-20-009021","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund II, L.P.; Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.","owner_display_name":"Tananbaum James B.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750000.0,"shares_display":"750,000","price_per_share":59.0,"price_display":"59.00","price_state":"stated","total_value":44250000.0,"total_display":"44,250,000.00","total_whole":"44,250,000","shares_owned_after":1134579.0,"shares_owned_after_display":"1,134,579","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider","n_lines":2},{"id":8647388,"accession":"0001209191-19-049680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049680","line_url":"/filing/0001209191-19-049680#line-1","is_derivative":false,"issuer_cik":"0001562157","issuer_name":"10x Genomics, Inc.","issuer_ticker":"TXG","issuer_name_source":null,"issuer_url":"/issuer/0001562157","owner_cik":null,"owner_name":"Foresite Capital Fund II, L.P.; Foresite Capital Management I, LLC; Tananbaum James B.; Foresite Capital Management II, LLC; Foresite Capital Fund I, L.P.","owner_display_name":"Foresite Capital Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":39.0,"price_display":"39.00","price_state":"stated","total_value":7312500.0,"total_display":"7,312,500.00","total_whole":"7,312,500","shares_owned_after":187500.0,"shares_owned_after_display":"187,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-16","scope":"insider"},{"id":4592519,"accession":"0001181431-13-053974","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-8","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4817.0,"shares_display":"4,817","price_per_share":6.7664,"price_display":"6.77","price_state":"stated","total_value":32593.7488,"total_display":"32,593.75","total_whole":"32,594","shares_owned_after":2079569.0,"shares_owned_after_display":"2,079,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-24","filed_date":"2013-10-16","scope":"insider"},{"id":4592516,"accession":"0001181431-13-053974","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-7","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":7.4616,"price_display":"7.46","price_state":"stated","total_value":55962.0,"total_display":"55,962.00","total_whole":"55,962","shares_owned_after":2074752.0,"shares_owned_after_display":"2,074,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-10-16","scope":"insider"},{"id":4592507,"accession":"0001181431-13-053974","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-6","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5700.0,"shares_display":"5,700","price_per_share":7.4532,"price_display":"7.45","price_state":"stated","total_value":42483.24,"total_display":"42,483.24","total_whole":"42,483","shares_owned_after":2067252.0,"shares_owned_after_display":"2,067,252","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-10-16","scope":"insider"},{"id":4592504,"accession":"0001181431-13-053974","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-5","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.9908,"price_display":"6.99","price_state":"stated","total_value":69908.0,"total_display":"69,908.00","total_whole":"69,908","shares_owned_after":2061552.0,"shares_owned_after_display":"2,061,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-03","filed_date":"2013-10-16","scope":"insider"},{"id":4592500,"accession":"0001181431-13-053974","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-4","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5005.0,"shares_display":"5,005","price_per_share":6.7391,"price_display":"6.74","price_state":"stated","total_value":33729.1955,"total_display":"33,729.20","total_whole":"33,729","shares_owned_after":2051552.0,"shares_owned_after_display":"2,051,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-22","filed_date":"2013-10-16","scope":"insider"},{"id":4592498,"accession":"0001181431-13-053974","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-3","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1811.0,"shares_display":"1,811","price_per_share":6.8362,"price_display":"6.84","price_state":"stated","total_value":12380.3582,"total_display":"12,380.36","total_whole":"12,380","shares_owned_after":2046547.0,"shares_owned_after_display":"2,046,547","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-21","filed_date":"2013-10-16","scope":"insider"},{"id":4592494,"accession":"0001181431-13-053974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-2","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8120.0,"shares_display":"8,120","price_per_share":6.9025,"price_display":"6.90","price_state":"stated","total_value":56048.3,"total_display":"56,048.30","total_whole":"56,048","shares_owned_after":2044736.0,"shares_owned_after_display":"2,044,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-10-16","scope":"insider"},{"id":4592488,"accession":"0001181431-13-053974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-053974","line_url":"/filing/0001181431-13-053974#line-1","is_derivative":false,"issuer_cik":"0001131543","issuer_name":"AMBIT BIOSCIENCES CORP","issuer_ticker":"AMBI","issuer_name_source":null,"issuer_url":"/issuer/0001131543","owner_cik":null,"owner_name":"Foresite Capital Management I, LLC; Foresite Capital Fund I, L.P.; Tananbaum James B.","owner_display_name":"Foresite Capital Management I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36616.0,"shares_display":"36,616","price_per_share":6.7717,"price_display":"6.77","price_state":"stated","total_value":247952.5672,"total_display":"247,952.57","total_whole":"247,953","shares_owned_after":2036616.0,"shares_owned_after_display":"2,036,616","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-05-17","filed_date":"2013-10-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770787","name":"10x Genomics, Inc.","url":"/issuer/0001770787","role":"Ten percent owner","n_filings":3,"first_seen":"2019-09-16","last_seen":"2020-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001131543","name":"AMBIT BIOSCIENCES CORP","url":"/issuer/0001131543","role":"Ten percent owner","n_filings":1,"first_seen":"2013-10-16","last_seen":"2013-10-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001562157","retrieved_at":"2026-08-22T06:20:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}